STUDY OF ALLERGIZING ACTIVITY OF THE DRUG «NETINFLA №2»

Successful introduction of new medicines into clinical practice presupposes the proven safety of their use. For this purpose, it is important to conduct preclinical pilot studies. Scientific methods are used to assess and prove the safety of drugs, as a requisite for the use of new drugs created for the first time in humans is previous conduct of toxicological studies on laboratory animals. One of the necessary toxicological studies is the study of allergizing activity